Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk
- PMID: 19589049
- DOI: 10.1586/ern.09.62
Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk
Abstract
Medication nonadherence is a major obstacle to translating treatment efficacy from research settings into effectiveness in clinical practice for patients with affective disorders. Adherence to beneficial drug therapy is associated with lower mortality compared with poor adherence. Reduced adherence is associated with increased suicide risk, especially when lithium is discontinued. The aim of this paper is to review the prevalence, predictors and methods for improving medication adherence in unipolar and bipolar affective disorders. Studies were identified through Medline and PsycInfo searches of English language publications between 1976 and 2009. This was supplemented by a hand search and the inclusion of selected descriptive articles on good clinical practice. Estimates of medication nonadherence for unipolar and bipolar disorders range from 10 to 60% (median: 40%). This prevalence has not changed significantly with the introduction of new medications. There is evidence that attitudes and beliefs are at least as important as side effects in predicting adherence. The limited number of empirical studies on reducing nonadherence indicate that, if recognized, the problem may be overcome. Clinical data highlight the importance of extended courses of medication in improving the long-term prognosis of patients with affective disorders.
Similar articles
-
Enhancing medication adherence in patients with bipolar disorder.Hum Psychopharmacol. 2010 Jan;25(1):1-16. doi: 10.1002/hup.1081. Hum Psychopharmacol. 2010. PMID: 20041478 Review.
-
Treatment non-adherence in affective disorders.Acta Psychiatr Scand. 2002 Mar;105(3):164-72. doi: 10.1034/j.1600-0447.2002.1r084.x. Acta Psychiatr Scand. 2002. PMID: 11939969 Review.
-
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8. J Clin Psychiatry. 2009. PMID: 19686636 Review.
-
Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs posttraumatic stress disorder treatment program.Ann Pharmacother. 2009 Jul;43(7):1227-32. doi: 10.1345/aph.1M017. Epub 2009 Jul 7. Ann Pharmacother. 2009. PMID: 19584387
-
Adherence to treatment in mood disorders.Curr Opin Psychiatry. 2006 Jan;19(1):44-9. doi: 10.1097/01.yco.0000191501.54034.7c. Curr Opin Psychiatry. 2006. PMID: 16612178 Review.
Cited by
-
Independent and medication related effects of bipolar disorder on thyroid and reproductive hormones in women.Sci Rep. 2025 Jul 24;15(1):26962. doi: 10.1038/s41598-025-11460-6. Sci Rep. 2025. PMID: 40707550 Free PMC article.
-
The effect of knowledge and expectations on adherence to and persistence with antidepressants.Patient Prefer Adherence. 2016 May 6;10:761-8. doi: 10.2147/PPA.S99803. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27226710 Free PMC article.
-
Recommendations on screening for depression in adults.CMAJ. 2013 Jun 11;185(9):775-82. doi: 10.1503/cmaj.130403. Epub 2013 May 13. CMAJ. 2013. PMID: 23670157 Free PMC article. No abstract available.
-
Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial.BMC Psychiatry. 2021 Nov 19;21(1):582. doi: 10.1186/s12888-021-03583-7. BMC Psychiatry. 2021. PMID: 34798853 Free PMC article. Clinical Trial.
-
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder.Clinicoecon Outcomes Res. 2011;3:63-72. doi: 10.2147/CEOR.S17846. Epub 2011 Mar 15. Clinicoecon Outcomes Res. 2011. PMID: 21935334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical